Why the study?
Do antithrombotics like LMWH and warfarin improve survival and inhibit tumor growth and metastasis in cancer patients?
Population
Cancer patients with thrombosis or in a hypercoagulable state
Design
Review
Authors
Loading...
May support antithrombotic anti-angiogenesis in cancer; leaves open clinical outcome benefits.
Do antithrombotics like LMWH and warfarin improve survival and inhibit tumor growth and metastasis in cancer patients?
Antithrombotic agents such as LMWH and warfarin may offer therapeutic benefits beyond anticoagulation by inhibiting angiogenesis, tumor growth, and metastasis in cancer patients.
Shaker A. Mousa (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: